3bvn
From Proteopedia
Line 12: | Line 12: | ||
===High resolution crystal structure of HLA-B*1402 in complex with the latent membrane protein 2 peptide (LMP2) of Epstein-Barr virus=== | ===High resolution crystal structure of HLA-B*1402 in complex with the latent membrane protein 2 peptide (LMP2) of Epstein-Barr virus=== | ||
+ | |||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_19617632}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 19617632 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_19617632}} | ||
==Disease== | ==Disease== | ||
Line 20: | Line 26: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:17620730</ref><references group="xtra"/> | + | <ref group="xtra">PMID:19617632</ref><ref group="xtra">PMID:17620730</ref><references group="xtra"/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Kumar, P.]] | [[Category: Kumar, P.]] | ||
Line 54: | Line 60: | ||
[[Category: Ubl conjugation]] | [[Category: Ubl conjugation]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Nov 11 20:14:57 2009'' |
Revision as of 18:14, 11 November 2009
Contents |
High resolution crystal structure of HLA-B*1402 in complex with the latent membrane protein 2 peptide (LMP2) of Epstein-Barr virus
Template:ABSTRACT PUBMED 19617632
Disease
Known disease associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[142830], Spondyloarthropathy, susceptibility to, 1 OMIM:[142830], Stevens-Johnson syndrome, carbamazepine-induced, susceptibility to OMIM:[142830], Hypoproteinemia, hypercatabolic OMIM:[109700]
About this Structure
3BVN is a 6 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Kumar P, Vahedi-Faridi A, Saenger W, Merino E, Lopez de Castro JA, Uchanska-Ziegler B, Ziegler A. Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. J Biol Chem. 2009 Oct 23;284(43):29784-97. Epub 2009 Jul 18. PMID:19617632 doi:10.1074/jbc.M109.038497
- Kumar P, Vahedi-Faridi A, Merino E, Lopez de Castro JA, Volz A, Ziegler A, Saenger W, Uchanska-Ziegler B. Expression, purification and preliminary X-ray crystallographic analysis of the human major histocompatibility antigen HLA-B*1402 in complex with a viral peptide and with a self-peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Jul 1;63(Pt, 7):631-4. Epub 2007 Jun 29. PMID:17620730 doi:10.1107/S1744309107029077
Page seeded by OCA on Wed Nov 11 20:14:57 2009
Categories: Homo sapiens | Kumar, P. | Saenger, W. | Uchanska-Ziegler, B. | Vahedi-Faridi, A. | Ziegler, A. | Alternative splicing | Ankylosing spondylitis | Cytoplasm | Disease mutation | Glycation | Glycoprotein | Hla | Hla-b*14 | Hla-b*1402 | Hla-b14 | Hla-b1402 | Host-virus interaction | Human leukocyte antigen | Immune response | Immune system | Immunoglobulin domain | Major histocompatibility complex | Membrane | Mhc | Mhc i | Phosphoprotein | Plmp2 | Pyrrolidone carboxylic acid | Secreted | Transmembrane | Ubl conjugation